Finance

Beta
Lists
RVVTF:OTCMKTS
Revive Therapeutics Ltd
$0.024
-0.42%
(-0.000100) 1D
May 29, 11:00:33 AM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for RVVTF...
Open
$0.02
High
$0.02
Low
$0.02
Mkt. cap
14.65M
Avg. vol.
242.34K
Volume
18.23K
52-wk high
$0.06
52-wk low
$0.01
Beta
-2.06
Shares outstanding
418.56M
Open
$0.02
High
$0.02
Low
$0.02
Mkt. cap
14.65M
Avg. vol.
242.34K
Volume
18.23K
52-wk high
$0.06
52-wk low
$0.01
Beta
-2.06
Shares outstanding
418.56M
News stories
From sources across the web
About Revive Therapeutics Ltd
CEO-
Employees-
Founded2012
HeadquartersToronto, Ontario, Canada
SectorPharmaceutical industry
Websiterevivethera.com
Previous reportsAll values in CAD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in CAD
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Revenue
-
-
-
-
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
357.22K
336.32K
200.14K
283.25K
Operating expense
481.43K
336.39K
220.13K
283.30K
Total operating expenses
481.43K
336.39K
220.13K
283.30K
Operating income
-481.43K
-336.39K
-220.13K
-283.30K
Other non operating income
-
73.85K
-
-
EBT including unusual items
-577.18K
-9.60M
-281.75K
-238.72K
EBT excluding unusual items
-579.92K
-143.94K
-281.75K
-234.70K
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-577.18K
-9.60M
-281.75K
-238.72K
Net profit margin
-
-
-
-
Earnings per share
-
-
-
-
Interest and investment income
-
-
277.00
-
Interest expense
-
-
-
-
Net interest expenses
-
-
277.00
-
Depreciation and amortization charges
62.00
62.00
46.00
48.00
EBITDA
-481.36K
-336.32K
-220.08K
-283.25K
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer